Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021.
Saved in:
| Title: | Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021. |
|---|---|
| Authors: | Sehdev, Sandeep1 (AUTHOR) sehdev@toh.ca, Chambers, Alexandra2 (AUTHOR) alexandra.chambers@novartis.com |
| Source: | Current Oncology. Mar2022, Vol. 29 Issue 3, p1919-1931. 13p. 1 Diagram, 7 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11980052 |
|---|---|
| DOI: | 10.3390/curroncol29030156 |
